1. Home
  2. CBUS vs QTRX Comparison

CBUS vs QTRX Comparison

Compare CBUS & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.70

Market Cap

142.7M

Sector

Industrials

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$2.99

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBUS
QTRX
Founded
2010
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
142.7M
160.0M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
CBUS
QTRX
Price
$1.70
$2.99
Analyst Decision
Buy
Hold
Analyst Count
2
2
Target Price
$9.00
$6.00
AVG Volume (30 Days)
150.5K
800.3K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
74.33
N/A
EPS
N/A
N/A
Revenue
$3,639,000.00
$37,632,000.00
Revenue This Year
$112.72
$25.49
Revenue Next Year
$83.18
$10.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
64.52
52 Week Low
$1.09
$2.15
52 Week High
$4.19
$8.77

Technical Indicators

Market Signals
Indicator
CBUS
QTRX
Relative Strength Index (RSI) 45.34 45.94
Support Level $1.55 $2.27
Resistance Level $1.82 $3.85
Average True Range (ATR) 0.14 0.27
MACD -0.03 -0.01
Stochastic Oscillator 33.14 47.09

Price Performance

Historical Comparison
CBUS
QTRX

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: